Richard Glynne

Vorstandsvorsitzender bei

Belharra Therapeutics, Inc.

Health Technology

Commercial Services

Finance

Profil

Dr. Richard Glynne is a Chief Executive Officer at Belharra Therapeutics, Inc., a CSO at Inception Sciences, Inc. and a Venture Partner at Versant Venture Management LLC.
Dr. Glynne was previously employed as an Associate by NewCo /Ca/, an Executive Director by Novartis Institutes for Biomedical Research, Inc., an Executive Director of Genetics by Novartis AG, a VP Genetics by Phenomix Corp., and a Director Genomics by EOS Biotechnology, Inc. He received his doctorate degree from Imperial Cancer Research Fund Trading Ltd..

Aktive Positionen von Richard Glynne

Unternehmen	Position	Beginn
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Private Equity Investor	01.01.2018
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Corporate Officer/Principal	01.11.2018
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Vorstandsvorsitzender	01.01.2025

Alle aktiven Positionen von Richard Glynne

Ehemalige bekannte Positionen von Richard Glynne

Unternehmen	Position	Ende
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Corporate Officer/Principal	01.11.2018
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Private Equity Investor	01.01.2018
NOVARTIS AG	Private Equity Investor	01.01.2015
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Private Equity Investor	01.01.2004
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Corporate Officer/Principal	01.01.2002

Sehen Sie sich die Erfahrung von Richard Glynne im Detail an

Ausbildung von Richard Glynne

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Richard Glynne im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	9
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Health Technology
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Finance
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Commercial Services
Imperial Cancer Research Fund Trading Ltd. Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Health Technology
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Distribution Services
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Commercial Services